TABLE 2.
Study | |||||
---|---|---|---|---|---|
EFS | 2‐year | 5‐year | P value | HR | P value |
NMTRC003/003b (DFMO) | 0.864 (0.793, 0.942) | 0.852 (0.778, 0.933) | .0078* | 0.404 (0.203, 0.805) | .0100* |
BCC001 (No DFMO) | 0.783 (0.695, 0.883) | 0.656 (0.555, 0.775) | |||
OS | |||||
NMTRC003/003b (DMFO) | 0.988 (0.964, 1.000) | 0.951 (0.905, 0.999) | .0099* | 0.257 (0.085, 0.779) | .0163* |
BCC001 (No DFMO) | 0.944 (0.893, 0.999) | 0.816 (0.730, 0.912) | |||
EFS | |||||
MYCN‐A | |||||
DFMO | 0.919 (0.835, 1.000) | 0.919 (0.835, 1.000) | .0766 | 0.315 (0.081, 1.217) | .0938 |
No DFMO | 0.864 (0.749, 0.997) | 0.756 (0.614, 0.931) | |||
OS | |||||
MYCN‐A | |||||
DFMO | 1.000 (1.000, 1.000) | 0.973 (0.922, 1.000) | .0207* | 0.123 (0.015, 1.023) | .0525 |
No DFMO | 0.929 (0.838, 1.000) | 0.781 (0.641, 0.953) | |||
EFS | |||||
Non‐MYCN‐A | |||||
DFMO | 0.829 (0.722, 0.953) | 0.805 (0.692, 0.936) | .2697 | 0.607 (0.248, 1.486) | .2750 |
No DFMO | 0.813 (0.697, 0.948) | 0.673 (0.537, 0.844) | |||
OS | |||||
Non‐MYCN‐A | |||||
DFMO | 0.976 (0.930, 1.000) | 0.927 (0.850, 1.000) | .3948 | 0.553 (0.139, 2.201) | .4010 |
No DFMO | 0.973 (0.922, 1.000) | 0.887 (0.788, 0.998) |